Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
Schenk PW, van Fessem MA, Verploegh-Van Rij S, Mathot RA, van Gelder T, Vulto AG, van Vliet M, Lindemans J, Bruijn JA, van Schaik RH. Schenk PW, et al. Among authors: van gelder t, van fessem ma, van schaik rh, van vliet m. Mol Psychiatry. 2008 Jun;13(6):597-605. doi: 10.1038/sj.mp.4002057. Epub 2007 Jul 31. Mol Psychiatry. 2008. PMID: 17667959
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients.
Schenk PW, van Vliet M, Mathot RA, van Gelder T, Vulto AG, van Fessem MA, Verploegh-Van Rij S, Lindemans J, Bruijn JA, van Schaik RH. Schenk PW, et al. Among authors: van gelder t, van fessem ma, van schaik rh, van vliet m. Pharmacogenomics J. 2010 Jun;10(3):219-25. doi: 10.1038/tpj.2009.50. Epub 2009 Nov 3. Pharmacogenomics J. 2010. PMID: 19884907
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients.
van Schaik RH, Kok M, Sweep FC, van Vliet M, van Fessem M, Meijer-van Gelder ME, Seynaeve C, Lindemans J, Wesseling J, Van 't Veer LJ, Span PN, van Laarhoven H, Sleijfer S, Foekens JA, Linn SC, Berns EM. van Schaik RH, et al. Among authors: van t veer lj, van fessem m, van laarhoven h, van vliet m. Pharmacogenomics. 2011 Aug;12(8):1137-46. doi: 10.2217/pgs.11.54. Epub 2011 Aug 10. Pharmacogenomics. 2011. PMID: 21830868
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation.
van Besouw NM, Balk AH, van Vliet M, van der Meide PH, Maat AP, van Gelder T, Baan CC, Weimar W. van Besouw NM, et al. Among authors: van der meide ph, van gelder t, van vliet m. Transplant Proc. 2002 Nov;34(7):2942-3. doi: 10.1016/s0041-1345(02)03498-x. Transplant Proc. 2002. PMID: 12431667 Clinical Trial. No abstract available.
Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma.
van Beers EH, Huigh D, Bosman L, de Best L, Kuiper R, Spaan M, van Duin M, Sonneveld P, Dumee B, van Vliet MH. van Beers EH, et al. Among authors: van vliet mh, van duin m. J Mol Diagn. 2021 Jan;23(1):120-129. doi: 10.1016/j.jmoldx.2020.10.010. Epub 2020 Nov 2. J Mol Diagn. 2021. PMID: 33152501 Free article.
284 results